Related Experiment Video
Updated: Sep 30, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Mutational signatures and processes in hepatobiliary cancers
Ekaterina Zhuravleva1, Colm J O'Rourke1, Jesper B Andersen2
1Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Genomic analysis reveals diverse mutational signatures in hepatobiliary cancers, offering insights into tumor development and heterogeneity. Understanding these signatures can improve cancer prevention, treatment response prediction, and therapy development.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Hepatobiliary cancers exhibit significant clinical heterogeneity.
- Somatic mutations within cancer genomes provide clues to tumorigenesis.
- Mutational signatures reflect DNA damage and repair mechanisms.
Purpose of the Study:
- To analyze somatic mutations and their genomic context in hepatobiliary cancers.
- To infer the mechanisms driving tumorigenesis in these malignancies.
- To understand the origins of inter- and intra-tumoral heterogeneity.
Main Methods:
- Genomic analysis of thousands of patients with hepatobiliary cancers.
- Cataloguing somatic mutations and their DNA sequence context.
- Identifying and characterizing mutational signatures.
Main Results:
- Genomic analysis revealed diverse mutagenic processes in hepatobiliary cancers.
- Mutational signatures contribute significantly to cancer heterogeneity.
- A notable proportion of signatures in hepatocellular carcinoma and biliary tract cancer remain of unknown origin.
Conclusions:
- Mutational signatures are key to understanding hepatobiliary cancer evolution.
- Exploiting these signatures can advance cancer prevention strategies.
- Retrospective analysis may predict treatment response and guide novel therapies.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
08:29SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...